Bayer

AskMed
by Bayer

Congress Library

Global Cardiovascular Clinical Trialists Forum 2024

Posters

Bhatt FINEARTS Gamification Bhatt FINEARTS Gamification

Jawad Butt

Effect of Finerenone in Patients with HFmrEF or HFpEF According to Body Mass Index: A Prespecified Analysis of the FINEARTS-HF Trial

Click to access
Vaduganathan CKM Overlap Across Trials Vaduganathan CKM Overlap Across Trials

Jawad Butt

Effect of Finerenone in Patients with HFmrEF or HFpEF According to Frailty: A Prespecified Analysis of the FINEARTS-HF Trial

Click to access
Yang EQ-5D at baseline FINEARTS-HF Yang EQ-5D at baseline FINEARTS-HF

Alasdair Henderson

A Bayesian Analysis of the FINEARTS-HF Trial

Click to access
Vaduganathan Generalizability of the FINEARTS-HF Vaduganathan Generalizability of the FINEARTS-HF

Shingo Matsumoto

Initial Decline (dip) in Estimated Glomerular Filtration Rate with Initiation of Finerenone in Patients with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of FINEARTS-HF

Click to access
Vaduganathan Design and Baseline Vaduganathan Design and Baseline

Shingo Matsumoto

Number of Hospitalizations and Effect of Finerenone in FINEARTS-HF

Click to access
Vaduganathan Generalizability of the FINEARTS-HF Vaduganathan Generalizability of the FINEARTS-HF

John Ostrominski

Efficacy and Safety of Finerenone in Heart Failure with Preserved Ejection Fraction: A FINE-HEART Analysis

Click to access
Vaduganathan Design and Baseline Vaduganathan Design and Baseline

John Ostrominski

Finerenone and Blood Pressure in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Click to access
Vaduganathan Generalizability of the FINEARTS-HF Vaduganathan Generalizability of the FINEARTS-HF

Maria Pabon

Finerenone in Heart Failure with Improved Ejection Fraction: The FINEARTS-HF Trial

Click to access
Vaduganathan Design and Baseline Vaduganathan Design and Baseline

Mingming Yang

Finerenone and Quality of Life Assessed Using EuroQol 5-Dimension Questionnaire Level Sum Score (EQ-5D-5L LSS) in Patients with Heart Failure and Mildly Reduced or Preserved Ejection Fraction

Click to access

Follow Us

You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088. For Bayer products, you can report these directly to Bayer by clicking here.

 

This site provides access to balanced and evidence-based medical information related to our therapeutic areas of focus and is intended to serve as a medical resource for US HCPs. This may include investigational compounds or investigational new uses of FDA-approved Bayer products. The information provided is not intended to be promotional or provide medical advice. Please refer to the full Prescribing Information for approved indications, contraindications, warnings and precautions, and adverse events.

Copyright © 2024 Bayer

Bayer and the Bayer Cross are registered trademarks of Bayer.

sitemap